Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14(+) PD-L1(+) phenotype in prostate cancer.
about
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?Trial Watch-Oncolytic viruses and cancer therapyTrial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Small cell lung cancer: Recruitment of macrophages by circulating tumor cells.Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity.STAT3 inhibition for cancer therapy: Cell-autonomous effects only?Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer.PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapiesMolecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimens.The role of macrophage phenotype in regulating the response to radiation therapy.Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer.STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer.
P2860
Q26740601-B9915B28-CC22-4262-92DD-87A2565EC888Q28072347-67E41F13-7337-42BF-8F35-B067948E107DQ37079141-9B285E33-804F-4D6A-AF49-4D3BE525402DQ38773484-C5183370-02B5-4BA4-997B-36E47E848F3CQ39144794-13D0D6B5-AF93-4127-9B8F-59ED51AB6C0AQ39550361-AFB27065-AA9E-480B-8E62-FAC772278738Q42202612-2C1507DD-6B6E-4DF2-BF4C-BE09A95A4633Q42325128-82560DAB-D8D0-438E-BA34-857E0F05B648Q42370340-17E31C06-208B-4FB6-A069-492D8D510B27Q47591866-829426FC-7627-4977-89D3-71BD600CBB98Q47898330-62130FE4-B5DE-4E16-8657-095C7ACF12B6Q49634844-5B784FB4-F497-450F-92AC-35DD57103AA3Q51084411-B93CF502-BED8-410A-AE8A-A003C1999202Q52317592-7492ADD5-70D2-4B2C-8023-23947F9F058D
P2860
Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14(+) PD-L1(+) phenotype in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tumor stroma-derived factors s ...... tion toward a suppressive CD14
@nl
Tumor stroma-derived factors s ...... phenotype in prostate cancer.
@en
type
label
Tumor stroma-derived factors s ...... tion toward a suppressive CD14
@nl
Tumor stroma-derived factors s ...... phenotype in prostate cancer.
@en
prefLabel
Tumor stroma-derived factors s ...... tion toward a suppressive CD14
@nl
Tumor stroma-derived factors s ...... phenotype in prostate cancer.
@en
P2860
P50
P1433
P1476
Tumor stroma-derived factors s ...... ) phenotype in prostate cancer
@en
P2093
Josephine Salimu
Malcolm D Mason
P2860
P304
P356
10.4161/21624011.2014.955331
P577
2014-10-01T00:00:00Z